AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 54 min read$MET

MetLife (NYSE:MET) Misses Q2 CY2026 Revenue Estimates

MetLife (NYSE:MET) reported Q2 CY2026 revenue of $19.15 billion, up 6.9% year on year but below market estimates. Non-GAAP profit was $2.43 per share, 6.2% above analysts’ consensus. The article also notes MetLife’s BVPS declined over five years, stabilized near $38.59, and consensus projects BVPS rising to $59.52.

Original reporting
financialcontent.com
Published Aug 5, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 10:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
MetLife (NYSE:MET) Misses Q2 CY2026 Revenue Estimates — source image
Source · financialcontent.com
Decision brief

The 30-second read

$METNeutralLow
01

Why it matters

Q2 CY2026 shows a revenue shortfall versus consensus while non-GAAP EPS exceeded estimates; BVPS is described as stabilized, with consensus calling for strong BVPS growth over the next 12 months.

02

Market read

Traders get a mixed earnings read-through: revenue missed, EPS beat, and the stock reportedly stayed flat immediately after the release.

03

What to watch

The article emphasizes BVPS and net premiums earned, but provides no segment-level premium growth, investment income drivers, or management guidance that would clarify the durability of the quarter.

Relevance 4/10Novelty 4/10Timing: after-hours/next-session reaction to Q2 CY2026 results (stock flat immediately following)

Background

The piece frames MetLife’s revenue drivers (premiums, investment income from float, and fees) and discusses BVPS as a quality metric for insurers.

Company-level read

Ticker impact

$METNeutralMedium confidence
Context

MetLife reported Q2 CY2026 revenue of $19.15B, up 6.9% YoY, but it missed Wall Street’s revenue expectations.

Expected impact

Likely limited follow-through since the article says the stock was flat around $97 immediately after results.

Evidence & confidence

The text provides a concrete revenue miss and EPS beat, but no guidance change or new forward-looking datapoint beyond consensus BVPS growth.

Market effects

Sector

Insurer investors may refocus on net premiums earned and BVPS stability after a revenue miss despite EPS outperformance.

Regional

No specific regional market catalyst beyond US-listed earnings reaction.

Global

Limited, as the article centers on MetLife’s standalone quarter without broader industry/regulatory developments.

Counterpoint

What could challenge this read

The EPS beat and YoY revenue growth could indicate the miss was more about estimate positioning than deteriorating operating momentum.

Key entities

  • company
    MetLife

    US-listed insurer reporting Q2 CY2026 results with revenue miss and non-GAAP EPS beat.

Read at source← All news

Related articles

AUG 7
$METMed

MetLife reports $1.6bn adjusted earnings in second quarter 2026

MetLife reported second-quarter 2026 adjusted earnings of $1.6bn. Net investment income rose 18% to $6.7bn. Book value per share increased 8% to $38.59 and adjusted book value per share rose 3% to $57.71. The company returned over $1.1bn to shareholders via buybacks and dividends, and reported segment adjusted earnings gains across Group Benefits, Retirement and Income Solutions, Asia, EMEA, and MetLife Investment Management.

asiainsurancereview.com2 min
AUG 6
$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

insurancebusinessmag.com9 min
AUG 5
$METMed

METLIFE INC (MET): Results of Operations and Financial Condition

METLIFE INC (MET) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 ex992qfs8kdoc.htm EX-99.2 Document Table of Contents Exhibit 99.2 Second Quarter Financial Supplement June 30, 2026 2 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS

SEC EDGAR 8-K6 min
AUG 5
$METMedAI 8/10

MetLife profit rises on underwriting strength, volume growth

MetLife reported higher second-quarter adjusted profit, citing strong underwriting and broad volume growth. Premiums, fees and other revenue rose 7% to $13.7 billion. Group benefits adjusted profit increased 25% to $503 million, Asia earnings rose 21% and Latin America 15%. Net investment income climbed 18% to $6.7 billion, and adjusted EPS rose 20% to $2.43.

investing.com4 min
AUG 8
$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

baystreet.ca2 min
AUG 8
$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

yahoo.com4 min